MedPath

PROLEUKIN

PROLEUKIN

Approved
DIN Number

02130181

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02130181
AIG Number0126785001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L03AC01 ALDESLEUKIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ALDESLEUKINActive
Strength: 22000000 UNIT / VIAL
Monograph: ALDESLEUKIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.